1. Iron chelators inhibit amyloid-beta-induced production of lipocalin 2 in cultured astrocytes

    Dekens, D. W., De Deyn, P. P., Sap, F., Eisel, U. L. M. & Naudé, P. J. W., Jan-2020, In : Neurochemistry International. 132, 4 p., 104607.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Lipocalin 2 and the pathophysiology of Alzheimer's disease

    Dekens, D. W., 2019, [Groningen]: Rijksuniversiteit Groningen. 180 p.

    Research output: ThesisThesis fully internal (DIV)

  3. Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders

    Dong, Y., Dekens, D. W., De Deyn, P. P., Naude, P. J. W. & Eisel, U. L. M., Dec-2015, In : Antibodies. 4, 4, p. 369-408 40 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Dynamics of neutrophil gelatinase-associated lipocalin plasma and cerebrospinal fluid concentrations in older males

    Naude, P. J. W., Dekens, D. W., Eisel, U. L. M., den Daas, I. & De Deyn, P. P., Dec-2017, In : European Journal of Clinical Investigation. 47, 12, 7 p., 12853.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (9) »

Press / Media
  1. Selective manipulation of specific receptors may pave way for new MS therapies

    Yun Dong, Ulrich Eisel, Pieter Naudé, Csaba Nyakas, Eddy Zee, van der, Doortje Dekens & Wanda Douwenga


    3 items of Media coverage

    Press/Media: ResearchAcademic

View all (1) »

ID: 440487